4//SEC Filing
Londei Marco 4
Accession 0001209191-19-058549
CIK 0001370053other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:29 PM ET
Size
7.5 KB
Accession
0001209191-19-058549
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
Londei Marco
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-11-27$6.93/sh+46,202$320,180→ 68,579 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-11-27−46,202→ 4,946 totalExercise: $6.93Exp: 2025-08-13→ Common Stock (46,202 underlying)
Footnotes (2)
- [F1]The stock option is fully vested and immediately exercisable.
- [F2]In addition to the remaining options to purchase 4,946 shares of common stock as set forth in Table II, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 173,000 shares of common stock, which options vest according to their terms, and (ii) 68,579 shares of common stock held directly.
Documents
Issuer
ANAPTYSBIO, INC
CIK 0001370053
Entity typeother
Related Parties
1- filerCIK 0001654500
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:29 PM ET
- Size
- 7.5 KB